Every safety manager who has dealt with an alcohol breathalyzer eventually asks the same question about marijuana. If a handheld device can tell whether someone had a drink in the last few hours, why can't a similar device tell whether someone smoked or vaped recently? The short answer is that the science is not there yet. No marijuana breathalyzer has FDA clearance or DOT approval for workplace use, and the research explaining why is more interesting than the marketing claims you may have seen from device makers.
This article covers what a THC breath test is trying to measure, why it is harder to build than an alcohol breathalyzer, what federal researchers are actually finding, and what employers can put to work right now while the technology matures.
Why employers want a marijuana equivalent of the alcohol breathalyzer
Standard urine drug testing has a real limitation for THC. Because marijuana metabolites are fat soluble, they can show up in urine for days or weeks after use, long after any impairment has passed. That makes urine testing excellent for detecting a pattern of use over time, but weak at answering the one question a supervisor usually cares about after an incident or a call of reasonable suspicion: is this person under the influence right now.
An alcohol breathalyzer solves that problem for alcohol because ethanol partitions predictably between blood and breath, and decades of research tie a breath alcohol concentration to a specific blood alcohol level. Employers want the same tool for marijuana: something with a short recency window that reflects the last few hours rather than the last month. That demand is legitimate. The problem is that THC does not behave in breath the way ethanol does, and building a reliable device around it has turned out to be a much harder chemistry and engineering problem.
How breath THC capture works, in principle
When someone smokes or vapes cannabis, tiny amounts of THC can be carried in aerosol droplets exhaled from the lungs for a short period after use, typically described in the research as a window of a few hours. In theory, a breath collection device captures those droplets on a filter or cartridge, and a sensor or lab analysis then measures the THC present.
The federal government has an active research effort in this space. The National Institute of Standards and Technology runs a program studying the chemistry a marijuana breathalyzer would need, and its researchers have published work analyzing how much THC actually shows up in the breath of cannabis smokers and how quickly it fades. The findings so far explain why this remains a research question rather than a solved engineering problem. THC breath aerosols behave differently than alcohol vapor. Alcohol is a small, volatile molecule that people exhale in large, consistent quantities. THC arrives on much smaller aerosol particles in far smaller amounts, and the quantity varies a great deal between people, between products, and between individual breaths. That variability makes it hard to build a sensor that reliably converts a breath sample into a consistent, defensible number.
The honest current state: no approved device exists
It is worth saying plainly, because vendor marketing sometimes blurs this: there is no FDA cleared THC breathalyzer and no DOT approved THC breath testing device for workplace or safety sensitive testing. Any product marketed as a finished marijuana breathalyzer for compliance purposes should be treated with real skepticism until that changes.
The research is genuinely ongoing, and it is being pursued seriously by federal scientists, not abandoned. NIST's cannabis breathalyzer program exists specifically to establish the chemical foundations that a future device would need, which is a strong sign that no one considers the underlying science settled enough yet to standardize a test around it. Employers evaluating any breath based THC product today should ask directly what regulatory clearance the device has, and treat the absence of an answer as the answer.
Presence versus impairment: the harder problem underneath
Even if a device could reliably measure how much THC is present in a breath sample, that measurement would not by itself answer the question employers actually want answered, which is whether someone is impaired right now. Unlike alcohol, where a given blood alcohol concentration maps fairly consistently to a level of impairment across most people, THC does not behave that way. Detectable THC can persist in the body well after any impairing effects have worn off, especially in frequent users, and the relationship between a THC concentration and actual functional impairment varies widely from person to person.
This gap has been documented at the research level for years. A National Academies of Sciences report on the health effects of cannabis, published through the National Institutes of Health, specifically discusses the state of the evidence connecting THC blood levels to impairment and notes the difficulty of establishing a reliable per se limit the way states use blood alcohol content for alcohol. That same gap applies directly to any future breath test. A number on a screen, whether from urine, oral fluid, or breath, tells you THC is present. It does not by itself tell you whether the person is impaired at that moment. Employers who build policy around any THC test result should keep that distinction explicit rather than treating a positive result as proof of current impairment.
What employers can use today instead
None of this means employers are stuck with a thirty day urine window as their only option. Two tools available right now address the recency problem more directly than urine testing, and using them together is the most defensible approach available.
Oral fluid testing for a shorter detection window
Oral fluid, or saliva, testing detects recent drug use far more tightly than urine. For THC specifically, oral fluid generally reflects use within roughly the past day or two rather than the past several weeks, which lines up much better with a reasonable suspicion or post accident scenario where the question is what happened on this shift, not what happened last month.
Oral fluid testing has also moved forward on the regulatory side for federally regulated transportation employers. The Department of Transportation finalized a rule allowing oral fluid as an authorized specimen type for DOT drug testing, published in the Federal Register in 2023. That rule change does not mean oral fluid testing is fully operational for DOT purposes yet. Under the federal testing framework, laboratories have to be certified by the Department of Health and Human Services before employers can use oral fluid results to satisfy a DOT testing requirement, and that certification process has to run its course before DOT regulated employers can rely on oral fluid as a stand alone specimen. Non DOT employers are not bound by that same certification requirement and many have already adopted oral fluid collection for its speed, its harder to adulterate collection process, and its shorter detection window.
Documented impairment observation
The other tool that directly addresses the presence versus impairment problem is trained observation. A documented reasonable suspicion process, where a trained supervisor records specific, observable signs such as odor, speech, coordination, and behavior, and pairs that documentation with a same day drug test, builds a record that speaks to impairment in a way that a lab result alone cannot. This is not a replacement for testing. It is the piece that connects a positive result to an actual workplace event, and it holds up far better if a result is ever challenged.
State law is adding pressure of its own
On top of the science problem, a growing number of states have passed laws limiting what employers can do based on off duty, legal marijuana use outside of safety sensitive roles. These laws generally do not stop an employer from maintaining a drug free workplace or from acting on impairment at work. What they restrict is taking action purely on the basis of a positive test for a substance that was used legally off the clock, absent some sign of impairment on the job. That legal shift makes the presence versus impairment distinction even more important for policy drafting, because a policy built entirely around a urine positive is increasingly exposed in states with these protections, while a policy that documents observed impairment and uses a shorter recency window like oral fluid sits on firmer ground.
Breath vs. oral fluid vs. urine vs. hair for THC recency
| Specimen | Approximate THC recency window | What it mainly shows | Current status for employers |
|---|---|---|---|
| Breath | Hours, in research settings only | Possible very recent exposure | No FDA cleared or DOT approved device; research stage, not available for compliance testing |
| Oral fluid (saliva) | Roughly one to two days | Recent use, closer to a specific shift or incident | DOT rule finalized in 2023 but not yet operational for DOT testing pending certified labs; already used in many non DOT programs |
| Urine | Days to several weeks, depending on frequency of use | Use over a longer look back period, not a specific day | Long established, most common specimen type, standard DOT specimen |
| Hair | Roughly the past ninety days | Pattern of use over months | Common for pre employment and extended history screening, not useful for same day questions |
Read against each other, the pattern is clear. Nothing on the market today gives employers an hours level recency window the way an alcohol breathalyzer does for alcohol. Oral fluid comes closest among tools actually available now, which is why interest in it keeps growing as urine only programs run into the presence versus impairment problem described above. For programs that want that shorter window today, oral fluid drug test options are already built for exactly this use case.
Building this into policy
Employers do not need to wait for a marijuana breathalyzer to run a defensible program. A workable approach right now combines a documented reasonable suspicion protocol, a specimen type matched to the actual recency question being asked, and clear language about what a positive result does and does not prove. Programs that already run post accident or reasonable suspicion testing should look closely at whether urine's long window fits the question being asked, or whether a shorter window specimen paired with observation documentation would hold up better. For a broader look at how observation based programs complement lab testing, see our guide to impairment testing versus drug testing. For the policy side of handling legal off duty use, our overview of marijuana legalization and workplace drug testing covers what employers can and cannot act on state by state.
Frequently asked questions
Is there an FDA cleared or DOT approved THC breathalyzer available today?
No. As of now, no THC breath testing device has FDA clearance or DOT approval for workplace or safety sensitive drug testing. Research into the underlying chemistry is active, including work funded through the National Institute of Standards and Technology, but no device has reached the point of regulatory approval for compliance use.
Why is a marijuana breathalyzer harder to build than an alcohol breathalyzer?
Alcohol is exhaled in large, consistent amounts and its concentration in breath correlates predictably with blood alcohol level. THC leaves the body in breath as tiny aerosol particles in much smaller and more variable amounts, which makes it far harder to build a sensor that produces a consistent, defensible reading.
Does a positive THC test mean someone is impaired right now?
Not by itself. THC can remain detectable well after any impairing effects have ended, and researchers have not established a reliable link between a specific THC level and a specific degree of impairment the way blood alcohol concentration works for alcohol. A positive result shows presence, not necessarily current impairment.
What is the status of oral fluid testing for DOT regulated employers?
The Department of Transportation finalized a rule in 2023 authorizing oral fluid as a specimen type for DOT drug testing. Oral fluid testing is not yet operational for DOT purposes because the Department of Health and Human Services has to certify laboratories to perform DOT oral fluid testing before employers can use it to satisfy a federal testing requirement.
What can employers use today for a shorter THC detection window than urine?
Oral fluid testing is the most practical option available now, generally reflecting use within roughly the past one to two days rather than the several week window common with urine. Pairing it with a documented reasonable suspicion or post incident observation process strengthens the connection between a result and an actual workplace event.
Do state marijuana laws limit what employers can do with a positive THC test?
In a growing number of states, yes. Many of these laws restrict employers from taking action based solely on a positive test for legal, off duty marijuana use outside of safety sensitive positions, while still allowing employers to act on documented impairment at work. Policies should be reviewed against the specific state's requirements.
Sources
- National Institute of Standards and Technology, Chemical Foundations for a Cannabis Breathalyzer
- National Institute of Standards and Technology, Researchers Analyze THC in Breath of Cannabis Smokers
- Federal Register, Procedures for Transportation Workplace Drug and Alcohol Testing Programs, Oral Fluid Testing
- National Institutes of Health, National Academies Press, The Health Effects of Cannabis and Cannabinoids
- National Institute on Drug Abuse, Marijuana DrugFacts
This article is general information for employers and safety managers, not legal advice. Drug testing laws vary by state and change over time, so employers should confirm current requirements with qualified counsel before finalizing a policy.
